User talk:Goszkas/sandbox

Russell A DeBose-Boyd is a professor of molecular genetics at the University of Texas Southwestern Medical Center in Dallas, Texas, United States of America.

Early life and education
DeBose-Boyd was born and raised in Boswell, Oklahoma, United States of America. He studied at the Southeastern Oklahoma State University as an undergraduate, where he participated in the Minority Biomedical Research Support program (MBRS)). This programme was fundamental for his research career foundation: during the first national symposium on his first year he decided that he wanted to pursue career in science . He received his Bachelor’s degree in Chemistry with minors in Mathematics and Biology in 1993. He was awarded his Ph.D. from the University of Oklahoma Health Sciences Center in Oklahoma City in 1998 . After obtaining his doctoral degree he joined UT Southwestern Medical Center as fellow of the Jane Coffin Childs Memorial Fund for Medical Research working with Joseph L. Goldstein, M.D. and Michael S. Brown, M.D.

Career
Dr. DeBose-Boyd became an assistant professor of Molecular Genetics at the UT Southwestern Medical Center in 2003. During his academic appointment he received recognition and numerous awards. First, he became an Established Investigator of the American Heart Association in 2005 and then a W.M. Keck Distinguished Young Scholar in Medical Research in 2006. Dr. DeBose-Boyd was promoted to Associate Professor in 2007 and he was appointed a Howard Hughes Medical Institute Early Career Scientist in 2009. Finally, Dr. DeBose-Boyd was promoted to Professor in 2013 and was named the Beatrice and Miguel Elias Distinguished Chair in Biomedical Science in 2016. Chosen one of the 100 inspiring Black scientists in America in 2020.

Research
Dr. DeBose-Boyd dedicated his career to study cholesterol metabolism. His enzyme of interest is called HMG-CoA reductase, that function mainly as a rate-limiting enzyme in the synthesis of cholesterol; therefore a key in the metabolic regulation. His lab fucused on how sterol and nonsterol isoprenoids combine to regulate the degradation of HMG-CoA reductase. He works on disruption of metabolism in a rare human eye disease called Schnyder corneal dystrophy. Finally he study how sterol-accelerated degradation contributes to the overall regulation of the reductase and cholesterol synthesis in whole animals.